v3.26.1
Segments Reporting - Schedule of Reportable Business Segments (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Segment Reporting [Line Items]            
Net revenues    
Operating expenses 3,834,800   2,199,649   6,483,249 5,675,666
Depreciation and amortization    
Loss from operations (3,834,800)   (2,199,649)   (6,483,249) (5,675,666)
Interest expense    
Realized loss on crypto assets     (44,165)
Other income 149   173   298 354
Loss before provision for income taxes (3,834,651)   (2,199,476)   (6,527,116) (5,675,312)
Provision for income taxes    
Net Income (Loss) (3,834,651) $ (2,692,465) (2,199,476) $ (3,475,836) (6,527,116) (5,675,312)
Biopharmaceutical Segment [Member]            
Segment Reporting [Line Items]            
Net revenues    
Operating expenses 3,558,843   2,199,649   6,207,292 5,675,666
Depreciation and amortization    
Loss from operations (3,558,843)   (2,199,649)   (6,207,292) (5,675,666)
Interest expense    
Realized loss on crypto assets         (44,165)  
Other income 149   173   298 354
Loss before provision for income taxes (3,558,694)   (2,199,476)   (6,251,159) (5,675,312)
Provision for income taxes    
Net Income (Loss) (3,558,694)   (2,199,476)   (6,251,159) (5,675,312)
AI Infrastructure and Technologies segment [Member]            
Segment Reporting [Line Items]            
Net revenues    
Operating expenses 275,957     275,957
Depreciation and amortization    
Loss from operations (275,957)     (275,957)
Interest expense    
Realized loss on crypto assets          
Other income    
Loss before provision for income taxes (275,957)     (275,957)
Provision for income taxes    
Net Income (Loss) $ (275,957)     $ (275,957)